Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia

Anal Biochem. 2005 Apr 15;339(2):310-7. doi: 10.1016/j.ab.2005.01.014.

Abstract

We describe an isotope dilution liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of succinylacetone (SA) in urine for the diagnosis of hepatorenal tyrosinemia (HT1). The method used 15N-labeled 5(3)-methyl-3(5)-isoxazole propionic acid as internal standard. Urine samples were oximated with hydroxylamine hydrochloride at 80 degrees C, extracted by solvent-solvent extraction, and followed by derivatization of the butyl ester. The butylated isoxazole derivatives of SA and its internal standard were detected and quantified using positive ion electrospray LC-MS/MS with selected reaction monitoring. The turnaround time between injections was 10 min. Calibration curves were linear over the range of 0.0633-63.3 micromol/L. The intra- and interday assay variations were less than 7%. Mean recoveries of SA at three different concentrations ranged from 96 to 109%. During the course of this study, we identified 12 new patients with HT1 and applied this method to follow up the treatment of 4 of these patients as well as previously diagnosed HT1 patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Cyclohexanones / therapeutic use
  • Enzyme Inhibitors / therapeutic use
  • Heptanoates / urine*
  • Humans
  • Infant
  • Infant, Newborn
  • Mass Spectrometry
  • Middle Aged
  • Neonatal Screening / methods
  • Nitrobenzoates / therapeutic use
  • Reproducibility of Results
  • Tyrosinemias / drug therapy
  • Tyrosinemias / urine*

Substances

  • Cyclohexanones
  • Enzyme Inhibitors
  • Heptanoates
  • Nitrobenzoates
  • succinylacetone
  • nitisinone